The forest plot of subgroup analysis showed that positive Cbl-b expression was significantly associated with favorable prognosis in terms of OS in patients with HR-positive/HER2-positive, age > 35 years, histological grade 2-3, lymph nodes metastasis, and stage II-III breast cancer (Figure 3A). Here, CBLB is linked to breast cancer.